Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

New use of leuprorelin acetate in delaying senility and preventing climacteric syndrome

A leuprolide acetate, aging technology, applied in the directions of medical preparations, drug combinations, peptide/protein components containing active ingredients, etc., to improve E2 level, reduce sugar water consumption, and regulate hypothalamus-pituitary-gonad endocrine Effects of axis functions

Active Publication Date: 2008-01-09
北京博恩特药业有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There is no report about leuprolide acetate being used for delaying ovarian function aging and preventing and treating menopausal syndrome before the present invention

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New use of leuprorelin acetate in delaying senility and preventing climacteric syndrome

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Leuprolide acetate is made into microemulsion injection by conventional technology, one 1ml contains 4 micrograms of leuprolide acetate per milliliter, and is used for the treatment of menopausal syndrome. This injection is injected for adults, once a month, 1 bottle each time, 1 ml each time.

Embodiment 2

[0047] Leuprolide acetate is made into microemulsion injection by conventional technology, one bottle of 1 ml contains 20 micrograms of leuprolide acetate per ml, and is used for the treatment of menopausal syndrome; this injection is injected once a month for adults, one bottle at a time , one 1ml.

Embodiment 3

[0049] Leuprolide acetate is made into microemulsion injection by conventional technology, one 1 ml, each ml contains 120 micrograms of leuprolide acetate for the treatment of menopausal syndrome; this injection is injected once a month for adults, 1 stick at a time, One 1ml.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention is concerned with a kind of new purpose of Leuprorelin Acetate to stave procreation function and prevent and cure climacteric syndrome. Leuprorelin Acetate is a kind of activated ramification for hypothalamus gonadotropin releasing hormone (GnRH), and micro amount of Leuprorelin Acetate replaces function of effete hypothalamus with age to active and renew the endocrine function of gonad to pituitary-ovary or testicle and avoid the decline of ovary or testicle with age. It renews endocrine balance of hypothalamus- pituitary-gonad and staves the senescence of ovarian function and prevent climacteric syndrome.

Description

technical field [0001] The invention relates to a new application of medicine, in particular to a new pharmaceutical application of leuprorelin acetate. Background technique [0002] Leuprolide acetate is a highly active derivative of hypothalamic gonadotropin-releasing hormone (LH-RH). testis) to synthesize and secrete sex hormones. Long-term large-scale use can positively inhibit the synthesis and secretion of testicular or ovarian sex hormones, and is often used clinically for sex hormone-dependent tumors and other diseases such as prostate cancer, breast cancer, uterine fibroids, endometriosis, and precocious puberty in children Treatment. There is no report about leuprolide acetate being used for delaying ovarian function aging and preventing and treating menopausal syndrome before the present invention. Contents of the invention [0003] The purpose of the invention is to disclose the new pharmaceutical application of leuprolide acetate in delaying ovarian functio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/08A61K9/19A61K9/10A61P15/12
Inventor 冯前进冯玛丽梁卫郭光明崔晓星周晓庆
Owner 北京博恩特药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com